Cite

HARVARD Citation

    Chung, H. et al. (2017). Long‐term efficacy and safety of the dual 5‐alpha reductase blocker dutasteride on male androgenetic alopecia patients. Journal of dermatology. 44 (12), pp. 1408-1409. [Online]. 
  
Back to record